HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tasha A K Gandamihardja Selected Research

Adenocarcinoma

4/2006Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tasha A K Gandamihardja Research Topics

Disease

1Cholecystitis
11/2014
1Gallstones (Gallstone)
11/2014
1Esophageal Neoplasms (Esophageal Cancer)
04/2006
1Adenocarcinoma
04/2006

Drug/Important Bio-Agent (IBA)

1Anti-Bacterial Agents (Antibiotics)IBA
11/2014

Therapy/Procedure

1Laparotomy
11/2014
1Esophagectomy
04/2006